>Marché du diagnostic du cancer de la prostate en Asie-Pacifique, par type de produit (instruments, réactifs et consommables et accessoires), type de diagnostic (tests de dépistage préliminaires, tests de confirmation), groupe d'âge (adulte, pédiatrie et gériatrie), type (adénocarcinome prostatique, carcinome à petites cellules et autres), stade (cancer de la prostate localisé, cancer de la prostate récurrent/avancé et cancer de la prostate résistant à la castration (métastatique et non métastatique)), type d'échantillon (sang, tissu, urine et autres), utilisateur final (laboratoires de diagnostic indépendants, hôpitaux, instituts de recherche sur le cancer, cliniques, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail), pays (Japon, Chine, Australie, Corée du Sud, Inde, Singapour, Thaïlande, Indonésie, Malaisie, Philippines et reste de l'Asie-Pacifique) Tendances et prévisions de l'industrie jusqu'en 2028
Analyse et perspectives du marché : Marché du diagnostic du cancer de la prostate en Asie-Pacifique
Le marché du diagnostic du cancer de la prostate devrait connaître une croissance de marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 15,1% au cours de la période de prévision de 2021 à 2028 et devrait atteindre 1 703,86 millions USD d'ici 2028. L'accent croissant mis sur la charge de morbidité et la sensibilisation croissante à la maladie sont les principaux moteurs qui propulsent le marché du diagnostic du cancer de la prostate au cours de la période de prévision.
Le cancer de la prostate débute lorsque les cellules de la prostate commencent à se développer à un rythme anormal. On parle alors de cancer de la prostate. La prostate est une glande que l'on trouve uniquement chez les hommes. Elle produit une partie du liquide qui entre dans la composition du sperme. Le diagnostic du cancer de la prostate est une technique de détection du cancer principalement à un stade précoce pour mener à bien l'approche thérapeutique future qui peut augmenter le taux de survie.
Le développement du cancer de la prostate est étroitement lié à l'âge, avec l'augmentation de la population gériatrique, on observe une augmentation significative de l'incidence du cancer de la prostate. Cela augmentera la demande de produits de diagnostic pour la détection de la maladie et devrait agir comme un moteur pour le marché du diagnostic du cancer de la prostate. Le test PSA est l'un des principaux tests utilisés pour la détection du cancer de la prostate. Cependant, les contradictions entre le gouvernement et les prestataires de services médicaux concernant l'utilisation du PSA et des tests associés devraient restreindre le marché du diagnostic du cancer de la prostate. Le marché a un énorme potentiel de croissance et avec l'entrée de nouveaux acteurs du marché essayant d'entrer sur le marché en utilisant l'expansion commerciale via des accords de distribution et ayant investi dans le diagnostic du cancer de la prostate, on s'attend à ce que la taille du marché augmente et constituera une opportunité pour le marché du diagnostic du cancer de la prostate. L'obstacle lié à la réalisation du test de diagnostic du cancer peut affecter la vie de la population et c'est l'un des aspects les plus difficiles à surmonter en ce qui concerne les pays à faible revenu, ce qui affecte donc la communauté du diagnostic et constitue un défi pour le marché du diagnostic du cancer de la prostate.
Le rapport sur le marché du diagnostic du cancer de la prostate fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché du diagnostic du cancer de la prostate, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché du diagnostic du cancer de la prostate
Le marché du diagnostic du cancer de la prostate est classé en huit segments notables qui sont basés sur le type de produit, le type de diagnostic, la tranche d'âge, le type, le stade, le type d'échantillon, les utilisateurs finaux et le canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
- Sur la base du type de produit, le marché du diagnostic du cancer de la prostate est segmenté en instruments, réactifs et consommables et accessoires. En 2021, le segment des réactifs et consommables domine le marché du diagnostic du cancer de la prostate car il comprend les produits de test PSA, qui constituent le principal test recommandé pour les tests préliminaires.
- On the basis of diagnostics type, the prostate cancer diagnostics market is segmented into preliminary screening tests and confirmatory tests. In 2021, preliminary screening tests segment is dominating in the prostate cancer diagnostics market as the number of preliminary tests surpass the number of confirmatory tests by significant percentage.
- On the basis of age group, the prostate cancer diagnostics market is segmented into adult, pediatric and geriatrics. In 2021, geriatrics segment is dominating in the prostate cancer diagnostics market as around 60% of cases are diagnosed in men over 65 year of age.
- On the basis of type, the prostate cancer diagnostics market is segmented into prostatic adenocarcinoma, small cell carcinoma and others. In 2021, prostatic adenocarcinoma segment dominates the prostate cancer diagnostics market because more than 95 percent of prostate cancers are adenocarcinomas which develop in the gland cells and line of the prostate gland.
- On the basis of stage, the prostate cancer diagnostics market is segmented into localized prostate cancer, recurrent/advanced prostate cancer and castration-resistant prostate cancer (metastatic and non-metastatic). In 2021, localized prostate cancer segment dominates the prostate cancer diagnostics market as approximately 80 percent to 85 percent of all prostate cancers are detected in the local or regional stages which represent stages I, II and III.
- On the basis of sample type, the prostate cancer diagnostics market is segmented into blood, tissue, urine and others. In 2021, blood segment is dominating the prostate cancer diagnostics market as blood is the primary sample for the most common preliminary test that is PSA test and due to easy availability of blood, less complex procedure of blood sample collection doesn’t take much time which is expected to dominate the prostate cancer diagnostics market.
- On the basis of end users, the prostate cancer diagnostics market is segmented into independent diagnostic laboratories, hospitals, cancer research institutes, clinics, ambulatory surgical centers and others. In 2021, independent diagnostic laboratories segment is dominating the prostate cancer diagnostics market as the segment is specialized in conducting various prostate cancer diagnostics.
- On the basis of distribution channel, the prostate cancer diagnostics market is segmented into direct tender and retail sales. In 2021, direct tender segment dominates the prostate cancer diagnostics market as they are the primary source of procurement of reagents, consumables, devices and accessories by healthcare organizations and diagnostic labs.
Asia-Pacific Prostate Cancer Diagnostics Market Country Level Analysis
Asia-Pacific prostate cancer diagnostics market is analysed and market size information is provided by the country, product type, diagnostics type, age group, type, stage, sample type, end users and distribution channel as referenced above.
The countries covered in the Asia-Pacific prostate cancer diagnostics market report are the Japan, China, Australia, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines and rest of Asia-Pacific.
Asia-Pacific is expected to grow with the highest CAGR in the forecasted period as in the Asia-Pacific countries, the demand for prostate cancer diagnostics product is increasing very rapidly with the urbanization. China is expected to dominate in the Asia-Pacific prostate cancer diagnostics market as China has a large population and hence the total number of tests is higher as compared to other countries in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Strategic Initiatives by Manufacturers is Creating New Opportunities for Players in the Prostate Cancer Diagnostics Market
The prostate cancer diagnostics market also provides you with detailed market analysis for every country growth in prostate cancer diagnostics product sales, impact of advancement in the prostate cancer diagnostics and changes in regulatory scenarios with their support for the prostate cancer diagnostics market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Prostate Cancer Diagnostics Market Share Analysis
The prostate cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Asia-Pacific prostate cancer diagnostics market.
The major companies providing Asia-Pacific prostate cancer diagnostics market report are F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., HUMASIS, Hologic Inc., Accuquik Test Kits, Abbott, Siemens Healthcare GmbH, Beckman Coulter, Inc. (a subsidiary of Danaher), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation), bioMérieux SA, Fujirebio, Eurolyser Diagnostica GmbH among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
De nombreux lancements de produits et accords sont également initiés par les entreprises du monde entier, ce qui accélère également le marché du diagnostic du cancer de la prostate.
Par exemple,
- En janvier 2021, Hologic Inc. a annoncé avoir conclu un accord pour acquérir Biotheranostics, Inc. pour 230 millions USD. Cette société est le fournisseur d'un test de diagnostic moléculaire pour le cancer métastatique et le cancer du sein. Après l'acquisition complète, Hologic Inc. prendra un bon départ dans la détection oncologique mondiale pour les patients atteints de cancer et contribuera au chiffre d'affaires de l'entreprise.
La collaboration, les coentreprises et d’autres stratégies des acteurs du marché améliorent le marché des entreprises sur le marché du diagnostic du cancer de la prostate, ce qui offre également l’avantage aux organisations d’améliorer leur offre pour le marché du diagnostic du cancer de la prostate.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- product type LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- MARKET end users coverage GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- Epidemiology
- COMPARATIVE ANALYSIS WITH PARENT MARKET
- REGULATORY FRAMEWORK: ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
- REGULATORY SCENARIO IN JAPAN
- REGULATORY SCENARIO IN CHINA
- market overview
- drivers
- INCREASING PREVALENCE OF PROSTATE CANCER
- INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
- INCREASE IN GERIATRIC POPULATION
- LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
- DISEASE CAUSING PROSTATE CANCER
- RESTRAINTS
- CONTROVERSY RELATED TO PSA TESTING
- HIGH COST OF DIAGNOSTICS PROCEDURE
- LACK OF SKILLED AND CERTIFIED PROFESSIONALS
- OPPORTUNITIES
- RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
- REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
- GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
- RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
- Challenges
- STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
- OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
- INACCURATE DIAGNOSIS RESULTS
- IMPACT OF COVID-19 ON ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
- CONCLUSION
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
- overview
- reagents & consumables
- instruments
- accessories
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
- overview
- preliminary screening tests
- Prostate-Specific Antigen (PSA) Test
- Digital Rectal Exam (DRE) Test
- Confirmatory Tests
- PCA3 Test
- biopsy
- imaging tests
- ULTRASOUND
- MAGNETIC RESONANCE IMAGING (MRI)
- MULTIPARAMETRIC MRI
- MRI FUSION-GUIDED PROSTATE BIOPSY
- CT SCAN
- BONE SCAN
- PET/CT SCAN
- biomarker
- RNA BIOMARKERS
- DNA BIOMARKERS
- PROTEIN BIOMARKERS
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By type
- overview
- PROSTATIC ADENOCARCINOMA
- small cell carcinoma
- Others
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
- overview
- geriatrics
- adult
- Pediatric
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
- overview
- LOCALIZED PROSTATE CANCER
- RECURRENT/ADVANCED PROSTATE CANCER
- CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
- overview
- Blood
- tissue
- urine
- others
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
- overview
- Independent Diagnostic Laboratories
- hospitals
- Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- others
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
- overview
- direct tender
- retail sales
- Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, BY Country
- Asia-Pacific
- CHINA
- JAPAN
- India
- Australia
- SOUTH KOREA
- SINGAPORE
- THAILAND
- MALAYSIA
- INDONESIA
- Philippines
- REST OF Asia-Pacific
- ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY landscape
- company share analysis: Asia-Pacific
- SWOT
- company profile
- F. Hoffmann-La Roche Ltd
- COMPANY SNAPSHot
- REVENUE ANALYSIS
- product Portfoli0
- RECENT DEVELOPMENTs
- Abbott
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- siemens HEALTHCARE gmbh
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Beckman Coulter, Inc. (A Subsidiary of Danaher)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ACCUQUIK TEST KITS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- acon laboratories inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- Biomerieux sa
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- Eurolyser Diagnostica GmbH
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- FUJIREBIO
- COMPANY SNAPSHOT
- PRODUCT PORTFOLI
- RECENT DEVELOPMENTS
- GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HOLOGIC, INC.
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- HUMASIS
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Liste des tableaux
TABLE 1 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (USD Million)
TABLE 2 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By product type, 2019-2028 (UNits)
TABLE 3 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)
TABLE 4 Asia-Pacific preliminary screening tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 5 Asia-Pacific Confirmatory tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 6 Asia-Pacific imaging tests IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 7 Asia-Pacific Magnetic Resonance Imaging (MRI) IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 8 Asia-Pacific biomarker IN PROSTATE CANCER DIAGNOSTICS MARKET, By DIAGNOSTICS TYPE, 2019-2028 (USD million)
TABLE 9 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By type, 2019-2028 (USD million)
TABLE 10 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By age group, 2019-2028 (USD Million)
TABLE 11 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By Stage, 2019-2028 (USD Million)
TABLE 12 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By Sample Type, 2019-2028 (USD Million)
TABLE 13 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By End Users, 2019-2028 (USD Million)
TABLE 14 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By distribution channel, 2019-2028 (USD Million)
TABLE 15 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)
TABLE 16 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 17 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 18 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 19 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 20 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 21 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 22 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 23 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 24 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 25 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 26 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 27 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 28 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 29 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 30 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 31 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 32 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 33 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 34 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 35 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 36 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 37 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 38 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 39 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 40 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 41 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 42 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 43 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 44 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 45 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 46 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 47 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 48 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 49 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 50 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 51 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 52 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 53 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 54 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 55 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 56 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 57 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 58 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 59 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 60 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 61 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 62 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 63 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 64 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 65 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 66 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 67 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 68 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 69 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 70 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 71 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 72 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 73 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 74 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 75 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 76 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 77 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 78 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 79 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 80 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 81 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 82 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 83 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 84 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 85 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 86 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 87 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 88 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 89 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 90 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 91 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 92 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 93 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 94 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 95 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 96 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 97 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 98 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 99 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 100 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 101 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 102 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 103 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 104 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 105 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 106 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 107 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 108 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 109 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 110 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 111 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 112 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 113 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 114 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 115 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 116 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 117 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 118 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 119 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 120 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 121 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 122 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 123 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 124 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 125 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 126 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 127 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 128 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 129 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 130 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 131 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 132 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 133 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 134 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 135 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 136 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 137 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 138 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 139 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 140 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 141 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 142 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
TABLE 143 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)
TABLE 144 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 145 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 146 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 147 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 148 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 149 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)
TABLE 150 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)
TABLE 151 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)
TABLE 152 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)
TABLE 153 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)
TABLE 154 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)
TABLE 155 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 156 rest of Asia-Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)
Liste des figures
FIGURE 1 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: segmentation
FIGURE 2 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation
FIGURE 3 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: regional VS country MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: MARKET end users coverage GRID
FIGURE 10 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 12 INCREASING PREVALENCE OF PROSTATE CANCER, and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE Asia-Pacific prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the Asia-Pacific prostate cancer diagnostics market in 2021 & 2028
FIGURE 14 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET
FIGURE 16 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2020
FIGURE 17 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, 2021-2028 (USD Million)
FIGURE 18 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY product type, CAGR (2021-2028)
FIGURE 19 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE
FIGURE 20 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, 2020
FIGURE 21 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE 2021-2028 (USD Million)
FIGURE 22 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, CAGR (2021-2028)
FIGURE 23 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY DIAGNOSTICS TYPE, LIFELINE CURVE
FIGURE 24 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2020
FIGURE 25 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, 2021-2028 (USD Million)
FIGURE 26 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, CAGR (2021-2028)
FIGURE 27 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: By type, LIFELINE CURVE
FIGURE 28 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, 2020
FIGURE 29 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group , 2021-2028 (USD Million)
FIGURE 30 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, CAGR (2021-2028)
FIGURE 31 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY age group, LIFELINE CURVE
FIGURE 32 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2020
FIGURE 33 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, 2021-2028 (USD Million)
FIGURE 34 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, CAGR (2021-2028)
FIGURE 35 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY stage, LIFELINE CURVE
FIGURE 36 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2020
FIGURE 37 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, 2021-2028 (USD Million)
FIGURE 38 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, CAGR (2021-2028)
FIGURE 39 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY sample type, LIFELINE CURVE
FIGURE 40 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2020
FIGURE 41 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, 2021-2028 (USD Million)
FIGURE 42 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, CAGR (2021-2028)
FIGURE 43 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY end users, LIFELINE CURVE
FIGURE 44 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2020
FIGURE 45 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, 2021-2028 (USD Million)
FIGURE 46 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution channel, CAGR (2021-2028)
FIGURE 47 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY distribution, LIFELINE CURVE
FIGURE 48 Asia-Pacific Prostate cancer diagnostics market: SNAPSHOT (2020)
FIGURE 49 Asia-Pacific Prostate Cancer Diagnostics Market: BY COUNTRY (2020)
FIGURE 50 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 51 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 52 Asia-Pacific PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)
FIGURE 53 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
